265 related articles for article (PubMed ID: 28293928)
1. Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials.
Feng B; Xiang H; Jin H; Gao J; Huang S; Shi Y; Chen R; Chen B
Allergy Asthma Immunol Res; 2017 May; 9(3):220-228. PubMed ID: 28293928
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: A meta-analysis of randomized controlled trials.
Feng B; Wu J; Chen B; Xiang H; Chen R; Li B; Chen S
Am J Rhinol Allergy; 2017 Jan; 31(1):27-35. PubMed ID: 28234149
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.
Kim JY; Jang MJ; Kim DY; Park SW; Han DH
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4450-4458.e6. PubMed ID: 34464748
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis.
Kulalert P; Phinyo P; Lao-Araya M
World Allergy Organ J; 2022 Sep; 15(9):100691. PubMed ID: 36119654
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy for treating allergic conjunctivitis.
Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham S
Cochrane Database Syst Rev; 2011 Jul; (7):CD007685. PubMed ID: 21735416
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
10. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
Durham SR; Creticos PS; Nelson HS; Li Z; Kaur A; Meltzer EO; Nolte H
J Allergy Clin Immunol; 2016 Oct; 138(4):1081-1088.e4. PubMed ID: 27527264
[TBL] [Abstract][Full Text] [Related]
11. Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials.
Li Y; Yu SY; Tang R; Zhao ZT; Sun JL
Chin Med J (Engl); 2018 Nov; 131(21):2583-2588. PubMed ID: 30381592
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
Compalati E; Passalacqua G; Bonini M; Canonica GW
Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
[TBL] [Abstract][Full Text] [Related]
15. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
Nelson H; Cartier S; Allen-Ramey F; Lawton S; Calderon MA
J Allergy Clin Immunol Pract; 2015; 3(2):256-266.e3. PubMed ID: 25609326
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
17. Update on house dust mite immunotherapy: are more studies needed?
Nelson HS
Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):542-8. PubMed ID: 25115684
[TBL] [Abstract][Full Text] [Related]
18. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
Richards JR; Stumpf JL
Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
